Apie Therapeutics
Cary
About Apie Therapeutics
Apie Therapeutics develop and commercialize novel Apelin Receptor biased agonist drug therapies, activating the Apelinergic System focused on the promising therapy targets of the Apelinergic System.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $250.0K
- Last round: Debt Financing (Feb 2021)
- Website: apie-therapeutics.com
- Phone: 919.594.1985
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/apie-therapeutics-75916 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.